Polyketal Nanoparticles Co-Loaded with Mir-124 and Ketoprofen for Treatment of Rheumatoid Arthritis

Menghui Zhao,Jiaqi Yao,Xiangxue Meng,Yaxin Cui,Tianyu Zhu,Fengying Sun,Youxin Li,Lesheng Teng
DOI: https://doi.org/10.1016/j.xphs.2021.01.024
IF: 3.8
2021-01-01
Journal of Pharmaceutical Sciences
Abstract:Ketoprofen, a non-steroidal anti-inflammatory drug, can effectively relieve pain associated with arthritis, and microRNA-124 (miR-124) can inhibit the progression of the disease. In this study, poly (cyclohexane-1,4-diylacetone dimethylene ketal) (PCADK) nanoparticles (NPs) co-loaded with ketoprofen and miR-124 were successfully prepared using an emulsified solvent evaporation method. The co-loaded NPs exhibited a mean particle diameter of 160 nm. The acid sensitivity of the NPs was determined through in vitro release experiments. An adjuvant-induced arthritis rat model of arthritis was established for evaluating the pharmacodynamics of the NPs through clinical scoring and degree of swelling. The PCADK NPs exhibited more potent pharmacodynamic effects owing to the acid-sensitive properties of the carrier materials, compared with Poly (lactic-co-glycolic acid) (PLGA) NPs. Furthermore, PCADK co-loaded NPs exhibited superior anti-inflammatory effects compared to NPs loaded with either miR-124 or ketoprofen alone. In conclusion, co-delivery of ketoprofen and miR-124 through NPs is a promising strategy for the treatment of arthritis.
What problem does this paper attempt to address?